BBP Holdings — Virtus LifeSci Biotech Products ETF
All 63 reported holdings of Virtus LifeSci Biotech Products ETF (BBP) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Immunitybio, Inc. | 4.80% | $2.85M |
| Dreyfus Government Cash Manage | 3.15% | $1.87M |
| Apellis Pharmaceuticals, Inc. | 2.59% | $1.54M |
| Kalvista Pharmaceuticals, Inc. | 2.52% | $1.49M |
| Moderna, Inc. | 2.49% | $1.48M |
| Iovance Biotherapeutics, Inc. | 2.44% | $1.45M |
| Mirum Pharmaceuticals, Inc. | 2.39% | $1.42M |
| Axsome Therapeutics, Inc. | 2.24% | $1.33M |
| Kiniksa Pharmaceuticals International PLC | 2.06% | $1.22M |
| Roivant Sciences Ltd. | 2.06% | $1.22M |
| Zai Lab Ltd. | 1.94% | $1.15M |
| Ligand Pharmaceuticals | 1.93% | $1.15M |
| Biocryst Pharmaceuticals, Inc. | 1.93% | $1.15M |
| Travere Therapeutics, Inc. | 1.93% | $1.14M |
| Novavax, Inc. | 1.93% | $1.14M |
| United Therapeutics Corp. | 1.84% | $1.09M |
| Geron Corp. | 1.81% | $1.07M |
| Biontech SE | 1.74% | $1.03M |
| Amgen, Inc. | 1.74% | $1.03M |
| Exelixis, Inc. | 1.74% | $1.03M |
| Biogen, Inc. | 1.73% | $1.03M |
| Gilead Sciences, Inc. | 1.73% | $1.03M |
| Tg Therapeutics, Inc. | 1.72% | $1.02M |
| Krystal Biotech, Inc. | 1.71% | $1.01M |
| Legend Biotech Corp. | 1.68% | $997.20K |
| Syndax Pharmaceuticals, Inc. | 1.68% | $995.57K |
| Arrowhead Pharmaceuticals, Inc. | 1.67% | $992.05K |
| Ascendis Pharma A/s | 1.66% | $984.73K |
| Agios Pharmaceuticals, Inc. | 1.64% | $971.68K |
| Halozyme Therapeutics, Inc. | 1.63% | $968.33K |
| Ardelyx, Inc. | 1.63% | $964.65K |
| Biomarin Pharmaceutical, Inc. | 1.61% | $956.90K |
| Incyte Corp. | 1.59% | $944.89K |
| Aurinia Pharmaceuticals, Inc. | 1.55% | $918.59K |
| Sarepta Therapeutics, Inc. | 1.55% | $917.78K |
| Regeneron Pharmaceuticals | 1.52% | $902.21K |
| Bridgebio Pharma, Inc. | 1.51% | $895.42K |
| Vertex Pharmaceuticals, Inc. | 1.51% | $894.51K |
| Beone Medicines Ltd. | 1.48% | $875.48K |
| Ionis Pharmaceuticals, Inc. | 1.48% | $875.29K |
| Crispr Therapeutics AG | 1.47% | $873.82K |
| Theravance Biopharma, Inc. | 1.47% | $871.85K |
| Madrigal Pharmaceuticals, Inc. | 1.44% | $856.28K |
| Kura Oncology, Inc. | 1.38% | $817.65K |
| Neurocrine Biosciences, Inc. | 1.38% | $815.30K |
| Ptc Therapeutics, Inc. | 1.37% | $813.90K |
| Acadia Pharmaceuticals, Inc. | 1.32% | $782.49K |
| Arcutis Biotherapeutics, Inc. | 1.28% | $757.20K |
| Tarsus Pharmaceuticals, Inc. | 1.25% | $739.91K |
| Alnylam Pharmaceuticals, Inc. | 1.24% | $736.28K |
| Harmony Biosciences Holdings, Inc. | 1.23% | $730.23K |
| Phathom Pharmaceuticals, Inc. | 1.23% | $727.97K |
| Crinetics Pharmaceuticals, Inc. | 1.23% | $726.85K |
| Immunocore Holdings PLC | 1.21% | $717.68K |
| Rhythm Pharmaceuticals, Inc. | 1.14% | $677.97K |
| Insmed, Inc. | 1.10% | $654.52K |
| Ultragenyx Pharmaceutical In | 1.09% | $644.90K |
| Nuvation Bio, Inc. | 0.84% | $499.56K |
| Esperion Therapeutics, Inc. | 0.83% | $491.62K |
| Adma Biologics, Inc. | 0.83% | $490.40K |
| Lenz Therapeutics, Inc. | 0.79% | $468.49K |
| Omniab, Inc. | 0.00% | $0 |
| Omniab, Inc. | 0.00% | $0 |